气道参与和干预非ACE抑制剂诱导的血管
Bartholomew J Bacak1, Michael S Castle1, Chantal Barbot2
1Department of Otolaryngology - Head and Neck Surgery, University of Rochester Medical Center, Rochester, New York, U.S.A.
The Laryngoscope
|October 30, 2023
概括
非血管激素转化酶抑制剂 (ACEI) 诱导的血管需要及时评估. 呼吸道干预的关键指标包括听力障碍,特定的血压读数,以及呼吸道胀的程度.
科学领域:
- 紧急医疗 紧急医疗
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 关键的护理关键的护理
背景情况:
- 血管,特别是非ACEI诱导的,在紧急情况下提出了诊断挑战.
- 识别患有气道损害风险的患者对于及时干预至关重要.
研究的目的:
- 为了表征非ACEI诱导的血管患者.
- 识别预测需要呼吸道干预的风险因素.
主要方法:
- 在4.5年内对181名患有非ACEI诱导的血管的成年患者进行了回顾性审查.
- 灵活的喉腔镜被用于评估;数据包括人口统计,生命体,症状和的位置.
- 统计分析确定了与气道干预相关的因素.
主要成果:
- 11名患者 (6.1%) 需要进行气道干预 (输管).
- 气道干预的重要预测因素包括发声障碍,腹筋血压,平均动脉压,以及 edematous 气道部位的存在/数量.
- 人口统计,先前的血管瘤史和ED治疗与呼吸道干预没有相关性.
结论:
- 失声症,特定的血压参数 (DBP,MAP) 和的解剖学程度是对非ACEI诱导的血管干预呼吸道的关键指标.
- 这些发现有助于对患有这种疾病的患者进行风险分层和管理决策.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
674
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
674
Antihypertensive Drugs: Direct Renin Inhibitors
650
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
650
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
438
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
438
Cardiopulmonary Resuscitation II: ACLS Airway Management
16
Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
16
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
312
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
312
Antihypertensive Drugs: Angiotensin II Receptor Blockers
752
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
752


